Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Ziftomenib & Acute myeloid leukemia (AML), ziftomenib has received FDA approval for an Acute myeloid leukemia (AML) (NPM1m) indication, but not yet an EMA marketing authorization as of February 2026
…